Moderna, Sinovac Biotech gear up for final phase trials of Covid-19 Vaccine
- 4 years ago
Coronavirus (Covid-19) vaccines status check: Moderna, Sinovac Biotech gear up for final phase trials
Even as Covid-19 cases across the world cross 7.41 million, including 4,18,000 deaths, two of the leading names in the development of a vaccine — US firm Moderna Inc and China’s Sinovac Biotech Ltd — have made discernible progress with their experimental candidate.
In latest developments, Moderna Inc said a series of studies in mice of its mRNA-1273 vaccine has lent some assurance that it may not increase the risk of more severe disease even as the US firm prepares for the pivotal late-stage testing next month.
On the other hand, Chinese firm Sinovac Biotech’s inactivated vaccine — CoronaVac — is also set to enter phase 3 clinical trials in Brazil.
More than 100 potential Covid-19 vaccines are in various stages of development around the world. Among front runners currently in human trials are the Covid-19 vaccines being developed by AstraZeneca, Pfizer, BioNtech, Johnson & Johnson,
Even as Covid-19 cases across the world cross 7.41 million, including 4,18,000 deaths, two of the leading names in the development of a vaccine — US firm Moderna Inc and China’s Sinovac Biotech Ltd — have made discernible progress with their experimental candidate.
In latest developments, Moderna Inc said a series of studies in mice of its mRNA-1273 vaccine has lent some assurance that it may not increase the risk of more severe disease even as the US firm prepares for the pivotal late-stage testing next month.
On the other hand, Chinese firm Sinovac Biotech’s inactivated vaccine — CoronaVac — is also set to enter phase 3 clinical trials in Brazil.
More than 100 potential Covid-19 vaccines are in various stages of development around the world. Among front runners currently in human trials are the Covid-19 vaccines being developed by AstraZeneca, Pfizer, BioNtech, Johnson & Johnson,